Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Pediatr Gastroenterol Nutr ; 31(3): 275-9, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10997372

RESUMO

BACKGROUND: Numerous studies in Europe have documented a high prevalence of celiac disease in Down syndrome. This study was undertaken to estimate the prevalence of celiac disease in Down syndrome in the southeastern United States. METHODS: Seventy-five patients with Down syndrome were screened using immunoglobulin (Ig)A-anti antiendomysium antibodies, IgA-antigliadin antibodies, and total IgA level. When either antiendomysium or antigliadin antibodies produced positive findings, patients were referred to a pediatric gastroenterologist for consideration of a duodenal biopsy. RESULTS: Thirteen percent (10/75) were positive for antiendomysium antibodies. Half of these patients were also positive for antigliadin antibodies. Six of 10 patients positive for antiendomysium antibodies underwent intestinal biopsy. Changes consistent with celiac disease were documented in five. Histologic findings ranged from focal to total villous atrophy. None had IgA deficiency. CONCLUSIONS: There was a high prevalence of positivity to antiendomysium antibody in Down syndrome. Antiendomysium antibody was a more sensitive screening test than antigliadin antibody. The prevalence of celiac disease in Down syndrome in the southeastern United States was 1 in 14 cases. Screening with antiendomysium antibody and IgA for all children with Down syndrome is recommended, even if there are no gastrointestinal symptoms.


Assuntos
Doença Celíaca/epidemiologia , Síndrome de Down/complicações , Adolescente , Adulto , Autoanticorpos/sangue , Biópsia , Doença Celíaca/complicações , Doença Celíaca/diagnóstico , Criança , Pré-Escolar , Síndrome de Down/imunologia , Duodeno/patologia , Feminino , Gliadina/imunologia , Humanos , Imunoglobulina A/sangue , Lactente , Masculino , Miofibrilas/imunologia , Prevalência , Sudeste dos Estados Unidos/epidemiologia
2.
Brain Res ; 869(1-2): 85-97, 2000 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-10865062

RESUMO

In utero cocaine exposure can adversely affect CNS development. Previous studies showed that cocaine inhibits neuronal differentiation in a dose-dependent fashion in nerve growth factor (NGF)-stimulated PC12 cells. Cocaine binds with high affinity to several neurotransmitter transporters, resulting in elevated neurotransmitter levels in nerve endings. To determine if cocaine inhibits neurite outgrowth through the effects of these neurotransmitters, we applied dopamine, norepinephrine, serotonin, and acetylcholine to NGF-induced PC12 cells. Dopamine was the only neurotransmitter to inhibit neurite outgrowth significantly in a dose-dependent pattern without affecting cell viability. Norepinephrine and acetylcholine did not affect neurite outgrowth, while serotonin enhanced it. Furthermore, GBR 12909, a potent dopamine transporter (DAT) inhibitor, yielded similar effects. We then showed PC12 cells express D(1) and D(2) receptors and DAT proteins. Dopamine uptake measured over time was significantly blocked by cocaine and GBR 12909 which may result in elevated extracellular dopamine. The role of dopamine receptors in PC12 differentiation was further examined by using D(1) and D(2) specific receptor agonists. Only the D(1) agonist, SKF-38393, had a significant dose-dependent inhibitory effect. In addition, a D(1) antagonist produced significant recovery of neurite outgrowth in cocaine-treated cells. These findings suggest that cocaine inhibitory effects on neuronal differentiation are mediated through its binding to the dopamine transporter, resulting in increased dopamine level in the synapses. Subsequently, up regulation of D(1) receptors alters NGF signaling pathways.


Assuntos
Encéfalo/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Cocaína/toxicidade , Glicoproteínas de Membrana , Proteínas de Membrana Transportadoras , Fator de Crescimento Neural/farmacologia , Proteínas do Tecido Nervoso , Neurônios/efeitos dos fármacos , Células PC12/efeitos dos fármacos , Animais , Encéfalo/citologia , Encéfalo/embriologia , Proteínas de Transporte/efeitos dos fármacos , Proteínas de Transporte/metabolismo , Diferenciação Celular/fisiologia , Dopamina/metabolismo , Antagonistas dos Receptores de Dopamina D2 , Proteínas da Membrana Plasmática de Transporte de Dopamina , Inibidores da Captação de Dopamina/farmacologia , Relação Dose-Resposta a Droga , Desenvolvimento Embrionário e Fetal/efeitos dos fármacos , Desenvolvimento Embrionário e Fetal/fisiologia , Feminino , Fator de Crescimento Neural/metabolismo , Neuritos/efeitos dos fármacos , Neuritos/metabolismo , Neuritos/ultraestrutura , Neurônios/citologia , Neurônios/metabolismo , Neurotransmissores/metabolismo , Neurotransmissores/farmacologia , Células PC12/citologia , Células PC12/metabolismo , Piperazinas/farmacologia , Gravidez , Efeitos Tardios da Exposição Pré-Natal , Ratos , Receptores de Dopamina D1/agonistas , Receptores de Dopamina D1/antagonistas & inibidores , Receptores de Dopamina D1/metabolismo , Receptores de Dopamina D2/agonistas , Receptores de Dopamina D2/metabolismo
3.
Int J Dev Neurosci ; 18(8): 765-72, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11154845

RESUMO

In utero exposure to cocaine may result in altered neuronal development. Our previous studies demonstrated cocaine inhibits neurite outgrowth in NGF-induced PC12 cells through dopamine, by activation of D1 receptors. This study examined where cocaine interferes in the NGF signaling cascade. GSrasl cells that inducibly express activated forms of Ras upon treatment with dexamethasone were used. Morphological differentiation was quantified by counting cells bearing neurite-like processes after 72 h exposure to either dexamethasone or NGF alone, or with cocaine, dopamine or SKF-38393. Cocaine, dopamine, and the D1 agonist inhibited neurite-like process outgrowth in both dexamethasone and NGF-induced GSras1 cells. GAP-43 expression, used as a measure for biochemical differentiation was severely diminished in NGF and dexamethasone-induced GSras1 cells treated with cocaine. These results suggest that cocaine, dopamine and activation of D1 receptors affect the NGF signaling downstream, independent of ras expression, leading to altered neuronal differentiation.


Assuntos
Cocaína/farmacologia , Inibidores da Captação de Dopamina/farmacologia , Fator de Crescimento Neural/farmacologia , Neurônios/citologia , Transdução de Sinais/fisiologia , Proteínas ras/fisiologia , 2,3,4,5-Tetra-Hidro-7,8-Di-Hidroxi-1-Fenil-1H-3-Benzazepina/farmacologia , Animais , Anti-Inflamatórios/farmacologia , Diferenciação Celular/efeitos dos fármacos , Dexametasona/farmacologia , Dopamina/farmacologia , Agonistas de Dopamina/farmacologia , Proteína GAP-43/análise , Neurônios/química , Neurônios/fisiologia , Células PC12 , Ratos , Receptores de Dopamina D1/fisiologia
4.
Mol Genet Metab ; 64(1): 62-9, 1998 May.
Artigo em Inglês | MEDLINE | ID: mdl-9682220

RESUMO

In utero cocaine exposure can affect CNS development. Previous studies showed that cocaine inhibits neuronal differentiation in a dose-dependent fashion, in nerve growth factor (NGF)-stimulated PC12 cells, without affecting cell viability. NGF activates intracellular signaling proteins, specific immediate-early genes (IEG) including a transient peak of c-fos expression, and induction of late genes expression, leading to the neuronal phenotype. We hypothesized that cocaine interferes with NGF signaling. Therefore, we examined the pattern of c-fos expression in our cellular model. Time course of c-fos expression up to 72 h was determined in cells treated with NGF 20 ng/ml and cocaine 10 microgram/ml (a moderately toxic level) by RT-PCR analysis. Total RNA was isolated from cells, and levels of c-fos mRNA were estimated using gene-specific primers. In both control and experimental conditions, c-fos level was maximal at 0.5 h. In the control cells, c-fos expression declined rapidly to less than 5% of the 0.5h value, while in the cocaine-treated cells, c-fos level persisted through the 72-h exposure. Adding c-fos antisense to cells treated with NGF and cocaine resulted in significant improvement of neurite out-growth, from 28% (NGF + cocaine) to 89% (NGF + cocaine + c-fos antisense) of control differentiation after 72 h of exposure (Dunnet's T < 3.24). Inhibitory effects of cocaine on NGF-induced PC12 differentiation may be attributed to alteration of c-fos expression. Further studies will be required to examine the role of D1 receptor activation in mediating c-fos expression and to explore the effects of cocaine on other IEGs.


Assuntos
Diferenciação Celular/efeitos dos fármacos , Cocaína/farmacologia , Fatores de Crescimento Neural/farmacologia , Neurônios/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-fos/fisiologia , Animais , Tamanho Celular , Expressão Gênica/efeitos dos fármacos , Genes fos , Neuritos/efeitos dos fármacos , Neuritos/ultraestrutura , Neurônios/citologia , Oligonucleotídeos Antissenso/farmacologia , Células PC12 , Reação em Cadeia da Polimerase , Proteínas Proto-Oncogênicas c-fos/genética , RNA Mensageiro , Ratos , Fatores de Tempo , Ativação Transcricional
6.
Brain Res ; 729(2): 270-2, 1996 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-8876998

RESUMO

We extend our findings showing dose-dependent cocaine inhibition of differentiation in NGF-stimulated PC-12 cells without affecting cell viability by demonstrating that neurite extension is severely limited after 24 h, maximal effect is reached at 36 h and recovery is only partial. Cocaine metabolites lack these effects. A similar process may occur following human prenatal exposure, perhaps through cocaine-induced changes in gene expression or other intracellular signalling events.


Assuntos
Diferenciação Celular/efeitos dos fármacos , Cocaína/farmacologia , Fatores de Crescimento Neural/farmacologia , Células PC12/efeitos dos fármacos , Animais , Ratos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA